Plant Comparison
Horse Chestnut vs Stinging Nettle
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Horse Chestnut and Stinging Nettle: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Horse Chestnut | Stinging Nettle | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 7/10 | Stronger for Stinging Nettle |
| Cancer (anticancer research) | 2/10 | 7/10 | Stronger for Stinging Nettle |
| Inflammation (general) | 2/10 | 1/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
| Swelling / fluid retention | 7/10 | 1/10 | Stronger for Horse Chestnut |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The active mixture responsible for the venotonic and anti-oedematous effects; extracts are standardised to it. Escin is available as oral drages and a transdermal gel, with efficacy shown in chronic venous insufficiency and blunt-trauma injury.
Contribute to the antioxidant and anti-inflammatory action.
Thought to underlie the root's traditional use for BPH-related urinary symptoms.
The irritant compounds responsible for the fresh plant's sting; destroyed by cooking, drying or freeze-drying.
Pharmacological Actions
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Escin, the triterpene saponin of Aesculus hippocastanum, induces apoptosis and cell-cycle arrest and chemosensitizes breast, hepatocellular, lung and pancreatic cancer cells (preclinical, including in vivo xenograft models).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Escin shows antiproliferative and pro-apoptotic activity and enhances chemotherapy/immunotherapy efficacy in breast (MCF-7), hepatocellular, lung and pancreatic cancer models; it modulates NF-kappaB, p53, p38 MAPK/ERK and PD-L1 (preclinical).
Relief of haemorrhoid symptoms (venotonic)
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-rheumatic action
inferred from anticancer action
inferred from immunomodulator action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
Safety, Cautions & Contraindications
Use only standardised, processed seed extract. Raw conkers, leaves and bark contain toxic esculin and can cause poisoning - never eat raw horse chestnut.
May increase bleeding risk, so use caution with anticoagulant/antiplatelet medicines; use caution in kidney disease and avoid in pregnancy and breastfeeding.
Fresh plant causes stinging skin reaction (formic acid, histamine). Once cooked, dried, or freeze-dried, this is eliminated. Root tincture may interact with diuretics, antihypertensives, and antidiabetic drugs. Generally very safe in culinary and standard medicinal use. Avoid very high doses in pregnancy.
Duke (2002) rates stinging nettle as +++ and provides clinical evidence (score 2) for antiprostatitic activity (BPH — benign prostatic hyperplasia), consistent with Commission E approval for irritative urination symptoms associated with BPH. Dose: 4–6 g dried herb daily or 600–1200 mg root extract. The root preparations are used for BPH while leaf preparations are used for antiallergic and anti-inflammatory purposes. Duke also notes experimental antiarthritic and analgesic activity. Generally safe; the most common adverse effect is mild gastrointestinal upset (Duke, 2002).
External Ids
Botanical Description
Large deciduous tree, to 25-30 m, with a broad domed crown and stout, upward-arching branches. The leaves are opposite and palmately compound, with five to seven large, obovate, toothed leaflets radiating from a long stalk. In spring the tree bears large, showy, upright pyramidal flower spikes ('candles') of white flowers marked with yellow or pink at the base. The glossy brown seeds ('conkers') develop inside a spiky green husk and fall in autumn.[1]
Tall, upright perennial herb with square stems and opposite, deeply toothed, heart-shaped to lance-shaped leaves covered in fine stinging hairs that inject formic acid and histamine on contact. Tiny, greenish, petal-less flowers hang in branched, drooping clusters from the leaf axils.[11]
Habitat
Native to the Balkan Peninsula, and widely planted and naturalised as an ornamental and avenue tree across temperate Europe, North America and elsewhere.[1]
Grows abundantly on nitrogen-rich waste ground, hedgerows, riverbanks, woodland edges and disturbed soil; native to Europe, Asia, North Africa and North America and now found nearly worldwide.[11]
Harvesting
Young leaves and tops are gathered in spring before flowering, when stinging is least severe and nutrient content highest, using gloves; the root is dug in autumn or spring; seed is collected when ripe in late summer. Cooking, drying or freeze-drying neutralises the sting.[11]
Traditional Uses
Horse chestnut seed has a long folk history as a remedy for varicose veins, haemorrhoids and 'heavy legs', and was also used topically for rheumatic pain and bruising. Modern use is almost exclusively as a standardised seed extract for chronic venous insufficiency, confirming this traditional venous-support reputation.[1]
Nettle leaf has a long tradition as a nutritive spring tonic, diuretic and anti-inflammatory remedy for joint pain and rheumatism, while the root has a well-documented traditional and modern use for the irritative urinary symptoms of benign prostatic hyperplasia; the seed has a lighter tradition as a kidney tonic.[11, 12, 13]
Preparations
Dosage
Clinical studies commonly use extracts standardised to around 100-150 mg escin daily, in divided doses. Educational reference only, not a prescription.
The EU herbal monograph gives semi-solid dosage forms containing the equivalent of 0.4% triterpene glycosides calculated as protoaescigenin (or, depending on the preparation, 0.85-20% herbal preparation), applied as a thin layer to the affected area 1-3 times daily, in adults and elderly. Educational reference only, not a prescription.
The EU herbal monograph on nettle leaf gives 2-4 g as a single dose for herbal tea, 3-6 times daily, for a daily dose equivalent to 8-12 g, in adolescents, adults and elderly; a 1:5 liquid extract at 30-40 drops 3-4 times daily and several dry extracts are also listed. Not to be used for more than 4 weeks, and not recommended under 12 years. Educational reference only, not a prescription.
Traditional and Commission E sources suggest around 600-1200 mg root extract daily for BPH-related urinary symptoms. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Idris, S. and Mishra, A. and Khushtar, M (2020) 'Phytochemical, ethnomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine', Journal of Basic and Clinical Physiology and Pharmacology, 31(5). doi:10.1515/jbcpp-2019-0115 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2019-0115 - Penaranda Figueredo, F.A. and Vicente, J. and Barquero, A.A. and Bueno, C.A (2024) 'Aesculus hippocastanum extract and the main bioactive constituent beta-escin as antivirals agents against coronaviruses, including SARS-CoV-2', Scientific Reports, 14(1), pp. 6418. doi:10.1038/s41598-024-56759-y Preclinical
https://doi.org/10.1038/s41598-024-56759-y - Idris, S. and Mishra, A. and Khushtar, M (2023) 'Phytochemical Estimation and Therapeutic Amelioration of Aesculus hippocastanum L. Seeds Ethanolic Extract in Gastric Ulcer in Rats Possibly by Inhibiting Prostaglandin Synthesis', Chinese Journal of Integrative Medicine, 29(9), pp. 818-824. doi:10.1007/s11655-023-3734-9 Preclinical
https://doi.org/10.1007/s11655-023-3734-9 - Quarta, S. and Santarpino, G. and Carluccio, M.A. and Calabriso, N. and Scoditti, E. and Siculella, L. and Damiano, F. and Maffia, M. and Verri, T. and De Caterina, R. and Massaro, M (2022) 'Analysis of the Anti-Inflammatory and Anti-Osteoarthritic Potential of Flonat Fast, a Combination of Plant Extracts, Bromelain and Escin (Aesculus hippocastanum), Evaluated in In Vitro Models of Inflammation Relevant to Osteoarthritis', Pharmaceuticals, 15(10), pp. 1263. doi:10.3390/ph15101263 Preclinical
https://doi.org/10.3390/ph15101263 - Owczarek, A. and Kolodziejczyk-Czepas, J. and Wozniak-Serwata, J. and Magiera, A. and Kobiela, N. and Wasowicz, K. and Olszewska, M.A (2021) 'Potential Activity Mechanisms of Aesculus hippocastanum Bark: Antioxidant Effects in Chemical and Biological In Vitro Models', Antioxidants, 10(7), pp. 995. doi:10.3390/antiox10070995 Preclinical
https://doi.org/10.3390/antiox10070995 - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Pittler, M.H. and Ernst, E (2012) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003230.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub4 - Gallelli, L (2019) 'Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties', Drug Design, Development and Therapy, pp. 3425--3437. doi:10.2147/DDDT.S207720 Preclinical
https://doi.org/10.2147/DDDT.S207720 - Wu, X.J., Zhang, M.L., Cui, X.Y., Gao, F., He, Q., Li, X.J., Zhang, J.W., Fawcett, J.P. and Gu, J.K (2011) 'Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat', Journal of Ethnopharmacology, 139(1), pp. 201--206. doi:10.1016/j.jep.2011.11.003 Preclinical
https://doi.org/10.1016/j.jep.2011.11.003 - European Medicines Agency (HMPC) (2023) 'European Union herbal monograph on Aesculus hippocastanum L., semen, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters, pp. 1--8. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Mazrouei, R. and Raeisi, E. and Lemoigne, Y. and Heidarian, E (2019) 'Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and beta-escin on MCF7 Cells', Journal of Medical Signals and Sensors, 9(3), pp. 196-203. doi:10.4103/jmss.JMSS_44_18 Preclinical
https://doi.org/10.4103/jmss.JMSS_44_18 - Yuan, Y. and Wang, P. and Chen, S. and Cao, Z. and Ojha, S.C. and Sun, C. and Wang, G. and Wang, Z. and Gu, J. and Kang, J. and Xue, X (2025) 'Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma', Phytomedicine, 149, pp. 157532. doi:10.1016/j.phymed.2025.157532 Preclinical
https://doi.org/10.1016/j.phymed.2025.157532 - Hussain, Y. and Singh, J. and Meena, A. and Sinha, R.A. and Luqman, S (2023) 'Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells', Phytotherapy Research, 37(10), pp. 4819-4837. doi:10.1002/ptr.7948 Preclinical
https://doi.org/10.1002/ptr.7948 - Rimmon, A. and Vexler, A. and Berkovich, L. and Earon, G. and Ron, I. and Lev-Ari, S (2013) 'Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway', Biochemistry Research International, 2013, pp. 251752. doi:10.1155/2013/251752 Preclinical
https://doi.org/10.1155/2013/251752 - Domanski, D., Zegrocka-Stendel, O., Perzanowska, A., Dutkiewicz, M., Kowalewska, M., Grabowska, I., Maciejko, D., Fogtman, A., Dadlez, M. and Koziak, K (2016) 'Molecular Mechanism for Cellular Response to beta-Escin and Its Therapeutic Implications', PLoS One, 11(10). doi:10.1371/journal.pone.0164365 Preclinical
https://doi.org/10.1371/journal.pone.0164365 - Gloviczki, M.L., Kakkos, S.K., Urbanek, T., Chuback, J. and Nicolaides, A (2025) 'The role of venoactive compounds in the treatment of chronic venous disease', Journal of Vascular Surgery: Venous and Lymphatic Disorders, 13(5). doi:10.1016/j.jvsv.2025.102258 Preclinical
https://doi.org/10.1016/j.jvsv.2025.102258 - Santiago, F.R., Grillo, L., Amore, M., Carmelino, C., Trejo, J.M.R. and Ulloa, J.H (2026) 'Venoactive drugs in the management of chronic venous disease: A critical appraisal of the evidence and comparison with international guidelines', Vascular Pharmacology. doi:10.1016/j.vph.2026.107614 Preclinical
https://doi.org/10.1016/j.vph.2026.107614 - Pittler, M.H. and Ernst, E (2006) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews, 2006(1), pp. CD003230. doi:10.1002/14651858.CD003230.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub3
- Durovic, S., Kojic, I., Radic, D., Smyatskaya, Y.A. and others (2024) 'Chemical Constituents of Stinging Nettle (Urtica dioica L.): A Comprehensive Review on Phenolic and Polyphenolic Compounds and Their Bioactivity', International Journal of Molecular Sciences, 25(6), pp. 3430. doi:10.3390/ijms25063430 Meta-analysis / review
https://doi.org/10.3390/ijms25063430 - Semwal, P., Rauf, A., Olatunde, A., Singh, P. and others (2023) 'The medicinal chemistry of Urtica dioica L.: from preliminary evidence to clinical studies supporting its neuroprotective activity', Natural Products and Bioprospecting, 13(1), pp. 16. doi:10.1007/s13659-023-00380-5 Meta-analysis / review
https://doi.org/10.1007/s13659-023-00380-5 - Esposito, S., Bianco, A., Russo, R., Di Maro, A. and others (2019) 'Therapeutic Perspectives of Molecules from Urtica dioica Extracts for Cancer Treatment', Molecules, 24(15), pp. 2753. doi:10.3390/molecules24152753 Meta-analysis / review
https://doi.org/10.3390/molecules24152753 - Ziaei, R., Foshati, S., Hadi, A., Kermani, M.A.H. and others (2020) 'The effect of nettle (Urtica dioica) supplementation on the glycemic control of patients with type 2 diabetes mellitus: A systematic review and meta-analysis', Phytotherapy Research, 34(2), pp. 282-294. doi:10.1002/ptr.6535 Meta-analysis / review
https://doi.org/10.1002/ptr.6535 - Chrubasik, J.E., Roufogalis, B.D., Wagner, H. and Chrubasik, S (2007) 'A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix', Phytomedicine, 14(7-8), pp. 568-579. doi:10.1016/j.phymed.2007.03.014 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2007.03.014 - Koch, E (2001) 'Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tract symptoms', Planta Medica, 67(6), pp. 489-500. doi:10.1055/s-2001-16496 Preclinical
https://doi.org/10.1055/s-2001-16496 - Azimi, H., Khakshur, A.A., Aghdasi, I., Fallah-Tafti, M. and others (2012) 'A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents', Inflammation & Allergy Drug Targets, 11(3), pp. 207-221. doi:10.2174/187152812800392715 Meta-analysis / review
https://doi.org/10.2174/187152812800392715 - Bhusal, K.K., Magar, S.K., Thapa, R., Lamsal, A. and others (2022) 'Nutritional and pharmacological importance of stinging nettle (Urtica dioica L.): A review', Heliyon, 8(6), pp. e09717. doi:10.1016/j.heliyon.2022.e09717 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2022.e09717 - Dhouibi, R., Affes, H., Ben Salem, M., Hammami, S. and others (2020) 'Screening of pharmacological uses of Urtica dioica and other benefits', Progress in Biophysics and Molecular Biology, 150, pp. 67-77. doi:10.1016/j.pbiomolbio.2019.05.008 Meta-analysis / review
https://doi.org/10.1016/j.pbiomolbio.2019.05.008 - Saponaro, M., Giacomini, I., Morandin, G., Cocetta, V. and others (2020) 'Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)', International Journal of Molecular Sciences, 21(23), pp. 9178. doi:10.3390/ijms21239178 Preclinical
https://doi.org/10.3390/ijms21239178 - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Chrubasik, J.E., Roufogalis, B.D. and Chrubasik, S (2007) 'Evidence of effectiveness of herbal anti-inflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain', 21(7), pp. 675--683. Traditional / reference
https://scholar.google.com/scholar?q=Evidence%20of%20effectiveness%20of%20herbal%20anti-inflammatory%20drugs%20in%20the%20treatment%20of%20painful%20osteoarthritis%20and%20chronic%20low%20back%20pain - Schlichte, D.A. et al (2016) 'Efficacy of stinging nettle root extract for benign prostatic hyperplasia symptoms', 8(1), pp. 57--62. Traditional / reference
https://scholar.google.com/scholar?q=Efficacy%20of%20stinging%20nettle%20root%20extract%20for%20benign%20prostatic%20hyperplasia%20symptoms - European Medicines Agency (HMPC) (2008) 'Community herbal monograph on Urtica dioica L.; Urtica urens L., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-urtica-dioica-l-urtica-urens-l-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-urtica-dioica-l-urtica-urens-l-folium_en.pdf - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.